Executive Pay Packs Bizarre Perks: $100k Housing, Leased Cars
The finale in my compensation series at @endpts: the oddities and eccentricities of executive pay packages Feat. an annual $100k housing allowance for Novavax CEO, leased cars for Organogenesis execs, $23,000 internet for Regeneron's George Yancopoulos: https://t.co/yFQzKfnbeX
Seeking gRED Insiders’ Insights on Recent R&D Shifts
If you're inside gRED — one of biopharma's most iconic R&D units — now or recently left, I want to hear from you. What's driving these changes? How are they landing? Signal: adunn.68 — anything you share can be anonymous.
Biopharma Salary Rankings Reveal Top and Bottom Payers
Part 2 in our compensation series is now out: Who pays the best (and worst) in biopharma? A look at typical employee salaries Chock full of interactive + searchable data spanning big pharma, biotechs, CROs, generic drugmakers, and more: https://t.co/DyguxvyfFX https://t.co/v9aLsh8SVn
Biopharma Salary Secrets Revealed Through SEC Filings
How much is everyone in biopharma getting paid? Every year, I review several hundred SEC filings that give a glimpse into pay practices — both for execs and median employees As we roll out our pay series, I'm chatting live w/...
Biopharma CEOs Median Pay Jumps 13% to $5.35M
NEW: Here are biopharma's top-paid CEOs of 2025, taking in pay packages worth over $25M Median biopharma CEO pay for 2025 came in at $5.35M, up 13% from last year. The best-paid made far more & we have the receipts https://t.co/CBHCjCien5
Coinbase CEO's NewLimit Secures 2nd Largest 2026 Biotech Round
NewLimit, the anti-aging startup co-founded by Coinbase CEO Brian Armstrong, has closed the 2nd largest round in biotech for 2026: https://t.co/NBjbMOH8bX
Billions Bet on AI to Revolutionize Scientific Research
NEW: I took a dive into the billions flowing into new startups aiming to reinvent scientific research with AI. A lot unpacked here. It's far more interesting than the vague talk of solving disease and curing cancer: https://t.co/QYQYeA8WrT
Incyte Leverages AI Partnerships to Accelerate Future R&D
35-year-old Incyte is turning to AI to power through the coming decades, with new R&D deals with Edison Scientific & Genesis Molecular AI: https://t.co/5rinB9m8m4
Isomorphic Labs Eyes $2B Raise, Biotech’s Second‑largest
Great scoop from @RebeccaTorrenc5 & @mhbergen on Isomorphic Labs in "advanced discussions to raise more than $2 billion in a new round of funding" led by Thrive Capital Would be second-largest VC raise ever in biotech, only behind $3B for...
AI Talent Gravitating to Tech and Finance over Pharma
NEW: The next gen of AI talent is overwhelmingly looking to tech & finance, not pharma. It's about money, but it's also about more than pay. Across dozens of conversations with PhDs, postdocs, and industry scientists at #ICLR2026, my latest: https://t.co/horMCZIO9U...
Top AI Researcher Departs Genentech, Rethinks Pharma Future
“It got a bit too distant for me." Some insights into big pharma & AI from @kchonyc, a top AI researcher who talked with me about leaving Roche's Genentech and what he's thinking about next: https://t.co/IvzWUjc9Qd
AI Protein Design Advances, Yet Developability Remains Overlooked
Some new protein design competition results from Rio, showing the field keeps tackling harder and harder targets w/ AI methods Might be time to factor in other properties (developability, manufacturability)? https://t.co/h1niVwjnSS
Fathom Therapeutics Secures $47M Series A for AI‑Physics Drug Discovery
Exclusive: Fathom Therapeutics, formerly Atommap, has raised a $47M Series A, building a pipeline with its strategy of blending AI and physics approaches to drug discovery: https://t.co/iAlmJwCQK7
OpenAI Debuts GPT‑Rosalind, Entering Biopharma After Anthropic
NEW: OpenAI is the latest tech giant to move into biopharma, launching Thursday GPT-Rosalind, a life sciences-tailored version of its LLM Trails behind the very similar launch of Anthropic's Claude for Life Sciences by ~5 months. More here: https://t.co/zkXDwY0BBI
AI Agents Power Future Biotech Labs and Organizations
Live in 15 minutes — I'm talking with Stanford's @james_y_zou on his latest research in building laboratories and biotech orgs made of hundreds or even thousands of AI agents Register now to watch live, for free: https://t.co/xSa5NXkX4A